Selected Reads

Smartkarma

Equity Bottom-Up

<p><em>Join TC and Georgia for the much anticipated interview with MiMedx whistle-blower Mary Armstrong (@grownupbullyh8tr) as she shares the hard-to-believe facts surrounding her discovery of the company's fraudulent practices, the bizarre lengths MiMedx executives went to to disrupt her life even after she left the company, and how it felt in that moment when MiMedx CEO Parker "Pete" Petit was found guilty.The Chartcast is listener-supported! Your support for The Chartcast is a vote for deep,</em>…</p>

United States

MiMedx Group Inc. operates as a medical device company. The Company focuses on biomaterials for soft tissue repair, such as tendons, ligaments, and cartilage, as well as other biomaterial based products for other medical applications. MiMedx Group serves the medical industry worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00